We offer financial assistance for over 80 diseases and conditions, including chronic illnesses, rare diseases, and over 20 types of cancer.
PAN Foundation grants help you afford your out-of-pocket treatment costs or insurance premiums. Eligibility requirements and the amount of assistance you can receive vary by disease fund. Each grant is offered for a 12-month period, in full compliance with all relevant laws, regulations, and government guidelines.
As a leading charitable foundation for patient assistance, the PAN Foundation has helped millions of people in the U.S. afford their prescription medications and stay on treatment for their conditions. Learn about our financial assistance grants—and how you can apply quickly and easily online or by phone.

Featured disease funds
Thanks to our generous donors, we are connecting patients with financial assistance every day. Currently, our 30+ open funds include the following oncology funds:
Chronic lymphocytic leukemia (CLL)
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow affecting the circulatory system. Eligible patients can receive up to $8,000 per year in financial assistance for their out-of-pocket deductible, copay, and coinsurance costs (through a $4,000 initial grant and the opportunity to apply for additional funding).
Philadelphia chromosome negative myeloproliferative neoplasms (MPN)
Philadelphia chromosome negative myeloproliferative neoplasms (MPN) is a cancer associated with increased production of blood cells that affects the circulatory system. Eligible patients can receive up to $8,000 per year in financial assistance for their out-of-pocket deductible, copay, and coinsurance costs (through a $4,000 initial grant and the opportunity to apply for additional funding).
Waldenstrom macroglobulinemia (WM)
Waldenstrom Macroglobulinemia (WM), also known as lymphoplasmacytic lymphoma, is a type of blood cancer that originates in the lymphatic system and is characterized by an excess of abnormal white blood cells and proteins called immunoglobulins. WM is a subtype of non-Hodgkin’s lymphoma and affects the circulatory system. Eligible patients can receive up to $8,000 per year in financial assistance for their out-of-pocket deductible, copay, and coinsurance costs (through a $4,000 initial grant and the opportunity to apply for additional funding).

If it had not been for PAN, I would not have had access to the treatment. I would not be telling my story.”
Beatriz Restrepo Gomez, PAN grant recipient for CLL